Artificial pancreas improves nocturnal glucose control in children

02/27/2013 | PhysiciansBriefing.com

Youths with type 1 diabetes who used an artificial pancreas system had lower incidence of nocturnal hypoglycemia and better control of nocturnal glucose levels than those who used an insulin pump, an Israeli study showed. Researchers found no evidence of severe adverse reactions with the use of the artificial pancreas. The findings appear in the New England Journal of Medicine.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI